Colistimethate Sodium for Injection IP Manufacturers India
Leading Manufacturer & Supplier of Colistimethate Sodium for Injection IP 4.5MIU in India
Taj Pharma stands as a top-tier pharmaceutical company in India, renowned for its exceptional quality, adherence to global manufacturing standards, and consistent supply of critical care drugs. Among its extensive product portfolio, Colistimethate Sodium for Injection IP 4.5MIU holds significant importance. Manufactured in a state-of-the-art facility in Vapi, Gujarat, this life-saving antibiotic is distributed across India, Africa, the Middle East, and LATAM regions.
What is Colistimethate Sodium for Injection IP 4.5MIU?
Colistimethate Sodium for Injection IP 4.5MIU is a powerful polymyxin antibiotic used primarily for treating severe bacterial infections caused by multidrug-resistant Gram-negative bacteria. It is a last-resort therapy in critically ill patients, especially those suffering from hospital-acquired infections like pneumonia, sepsis, and urinary tract infections when other antibiotics have failed.
Administered under medical supervision, this injection works by disrupting the bacterial cell membrane, leading to cell death. Given the complexity and potency of this drug, it is reserved for specific cases in intensive care settings.
Why Choose Taj Pharma for Colistimethate Sodium for Injection IP 4.5MIU?
Taj Pharma is one of the most trusted Colistimethate Sodium for Injection IP 4.5MIU manufacturers in India, with a reputation built on quality, compliance, and customer satisfaction. Here’s why pharmaceutical buyers, hospitals, and healthcare institutions prefer Taj Pharma:
✅ Uncompromised Quality Assurance
- Complies with WHO-GMP, EU-GMP, and ISO standards.
- Stringent in-process testing and final product validation.
- Fully equipped analytical and microbiology laboratories for sterility assurance.
✅ Global Supply Chain & Export Capabilities
- Actively exports to Africa, the Middle East, LATAM, and South East Asia.
- Efficient and compliant cold-chain logistics for temperature-sensitive products.
- Registered and licensed in multiple countries, making Taj Pharma a preferred export partner.
✅ Regulatory Compliance and Safety
- Complete regulatory dossier support.
- Backed by pharmacovigilance data, batch stability reports, and COA documentation.
- Product manufactured in line with the Indian Pharmacopoeia (IP) standards.
Dosage & Administration of Colistimethate Sodium for Injection IP 4.5MIU
The administration of Colistimethate Sodium for Injection IP 4.5MIU should always be under the direct supervision of a medical professional. It is given intravenously and the dosage depends on the severity and type of infection, as well as the patient’s renal function.
- Adult dose: As recommended by the physician.
- Duration: Determined based on clinical response and microbiological eradication.
- Precaution: Do not self-administer or adjust the dose without medical advice.
Side Effects & Safety Warnings
While Colistimethate Sodium for Injection IP 4.5MIU is life-saving, it is associated with several potential side effects, especially if not administered correctly or without proper monitoring:
- Nephrotoxicity (Kidney toxicity)
- Neurotoxicity: Dizziness, slurred speech, paresthesia, vertigo
- Respiratory depression
- Rash, itching, gastrointestinal upset
It is important to monitor blood urea nitrogen (BUN) and serum creatinine during therapy. Patients with renal impairment require dose adjustment. The use of alcohol is not associated with known adverse effects during therapy, but caution is advised.
Use in Special Populations
Pregnancy
- Not recommended unless absolutely necessary.
- Limited human studies, but animal studies show potential fetal risks.
Breastfeeding
- Probably safe.
- Human data suggests minimal transfer to breast milk.
Pediatric Use
- Should only be used in pediatric patients under strict hospital settings and with adjusted dosing.
Applications in Clinical Settings
Colistimethate Sodium for Injection IP 4.5MIU is primarily used in ICU settings, especially for:
- Ventilator-associated pneumonia
- Septicemia
- Severe urinary tract infections
- Infections caused by carbapenem-resistant organisms (CRO)
Its utility has grown due to the rising incidence of antimicrobial resistance (AMR) worldwide. Taj Pharma’s injectable formulation ensures maximum bioavailability and consistent results in critical cases.
PAN India & Global Supplier
Taj Pharma is a leading PAN India supplier and global exporter of Colistimethate Sodium for Injection IP 4.5MIU. We also offer PCD Pharma Franchise opportunities, contract manufacturing, and third-party manufacturing for clients looking to expand their product portfolio.
📦 Available Packaging:
- Vials of 4.5MIU with sterile water for injection.
- Carton with literature and instructions.
🌍 Supply Regions:
- India (All States)
- South America
- Middle East
- Africa
- South East Asia
PCD Pharma Franchise & Contract Manufacturing
Looking to grow your business with a reliable pharmaceutical brand? Taj Pharma offers PCD franchise options and third-party manufacturing contracts with:
- Attractive margins
- Promotional support
- Timely dispatches and quality guarantee
We empower entrepreneurs, distributors, and wholesalers to thrive in competitive markets with backing from a global brand.
Buy Colistimethate Sodium for Injection IP 4.5MIU at Best Price
We guarantee the best ex-factory and export prices for our injectable antibiotics. Taj Pharma maintains inventory ready for dispatch for both domestic and international markets, ensuring uninterrupted treatment delivery for hospitals and distributors.
Keywords Targeted in This Article
Colistimethate Sodium for Injection IP 4.5MIU Manufacturer, PCD Pharma Franchise Colistimethate Sodium, Best Exporter of Colistimethate Sodium IP India, Injectable Antibiotic Manufacturer India, Taj Pharma Injectable Exports
📞 Contact Us Today
Partner with one of the most reliable pharmaceutical companies in India. For Colistimethate Sodium for Injection IP 4.5MIU manufacturing, PCD franchise, or export inquiries, reach out today.
📧 Email: info@tajpharma.com
📱 Phone: +91 84484 44095
📱 WhatsApp: +91 7400009975 / +91 7400009976
🌐 Website: www.tajpharmaindia.com
